Cytek Biosciences's total assets for Q4 2024 were $499.50M, an increase of 1.68% from the previous quarter. CTKB total liabilities were $103.76M for the fiscal quarter, a -1.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.